(NASDAQ: OMER) Omeros's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 22.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.2%.
Omeros's earnings in 2025 is -$153,091,000.On average, 2 Wall Street analysts forecast OMER's earnings for 2025 to be -$111,911,700, with the lowest OMER earnings forecast at -$119,528,727, and the highest OMER earnings forecast at -$104,294,673.
In 2026, OMER is forecast to generate -$74,119,529 in earnings, with the lowest earnings forecast at -$81,443,593 and the highest earnings forecast at -$66,795,465.